Fundraising FoxIllumina
also invests · investor profile2 known investors
Find your way into Illumina
Illumina Ventures is a venture capital firm focused on genomics and precision health, investing in early-stage companies developing breakthrough science and technology to improve human health. The firm provides capital, sequencing access, mentorship, and lab capabilities to portfolio companies through its Labs program.
Investors · 2
Acquisitions · 4
Early investors' stakes continue via these dealsProvider of data analysis acceleration for next-generation genome sequencing; acquired by Illumina in 2018.
GenoLogics Life Sciences Software, based in Victoria, BC, developed Clarity LIMS, laboratory information management software for genomics and life-sciences labs. Its software was used by over 120 genomic labs worldwide.
Helixis was a Caltech spin-out developing molecular diagnostic instruments, including a low-cost benchtop real-time PCR system called Eco for genetic testing in research and clinical labs.
Moleculo was a Stanford spinout that developed synthetic long-read DNA sequencing technology by fragmenting genomic DNA and reassembling short reads into long ones.
Frequently asked questions
- What does Illumina do?
- Illumina Ventures is a venture capital firm focused on genomics and precision health, investing in early-stage companies developing breakthrough science and technology to improve human health. The firm provides capital, sequencing access, mentorship, and lab capabilities to portfolio companies through its Labs program.
- Who are Illumina's investors?
- Illumina's investors include Beast Ventures, Illumina Accelerator.